Valuation: KPC Pharmaceuticals,Inc.

Market Cap 6.74B 996M 870M 804M 743M 1.4B 95.65B 1.43B 9.59B 3.76B 46.84B 3.74B 3.66B 161B P/E 2026 *
21.3x
P/E 2027 * 16.8x
Enterprise Value 6.74B 996M 870M 804M 743M 1.4B 95.65B 1.43B 9.59B 3.76B 46.84B 3.74B 3.66B 161B EV / Sales 2026 *
0.99x
EV / Sales 2027 * 0.93x
Free-Float
60.48%
Yield 2026 *
-
Yield 2027 * -
1 day+1.48%
1 week+5.44%
Current month+14.08%
1 month+4.21%
3 months-19.87%
6 months-30.77%
Current year-29.06%
1 week 7.96
Extreme 7.96
9.08
1 month 7.45
Extreme 7.45
9.08
Current year 7.45
Extreme 7.45
13.55
1 year 7.45
Extreme 7.45
15.08
3 years 7.45
Extreme 7.45
24.11
5 years 7.45
Extreme 7.45
26.09
10 years 5.95
Extreme 5.95
26.09
Manager TitleAgeSince
Director of Finance/CFO - 2023-01-02
President 55 2023-09-27
Corporate Officer/Principal 54 2007-05-31
Director TitleAgeSince
Director/Board Member 74 2018-11-01
Director/Board Member 50 2018-11-01
Director/Board Member 54 2018-11-01
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+5.44%-38.47%-49.97% 980M
-2.32%-6.53%+44.47%+156.94% 1,054B
-1.96%-5.36%+61.27%+58.20% 621B
-0.95%-3.49%+28.32%+80.70% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.08%-3.14%+20.03%+56.76% 195B
-0.56%-4.18%+16.56%+69.26% 163B
Average -1.19%-0.78%+17.41%+41.64% 355.72B
Weighted average by Cap. -1.71%-1.68%+33.24%+77.21%

Financials

2026 *2027 *
Net sales 6.8B 1B 877M 811M 749M 1.41B 96.41B 1.44B 9.67B 3.79B 47.21B 3.77B 3.69B 163B 7.23B 1.07B 933M 863M 797M 1.5B 103B 1.53B 10.29B 4.04B 50.23B 4.01B 3.92B 173B
Net income 317M 46.74M 40.85M 37.76M 34.89M 65.7M 4.49B 66.89M 450M 177M 2.2B 176M 172M 7.57B 400M 59.06M 51.61M 47.71M 44.08M 83.01M 5.67B 84.51M 569M 223M 2.78B 222M 217M 9.56B
Net Debt - -
Logo KPC Pharmaceuticals,Inc.
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
Employees
5,072
Date Price Change Volume
26-07-13 CN¥8.910 +1.48% 22,540,500
26-07-13 CN¥8.780 +6.04% 23,214,185
26-07-10 CN¥8.280 +1.85% 8,854,149
26-07-09 CN¥8.130 -1.93% 7,957,400
26-07-08 CN¥8.290 +0.97% 6,839,400
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.910CNY
Average target price
16.15CNY
Spread / Average Target
+81.26%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600422 Stock